These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 32380961

  • 1. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA, Déruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ.
    BMC Nephrol; 2020 May 07; 21(1):167. PubMed ID: 32380961
    [Abstract] [Full Text] [Related]

  • 2. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, Shaw JE.
    Am J Kidney Dis; 2018 Nov 07; 72(5):653-661. PubMed ID: 29784612
    [Abstract] [Full Text] [Related]

  • 3. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q, Luk AO, Lau ESH, Tam CHT, Ozaki R, Lim CKP, Wu H, Jiang G, Chow EYK, Ng JK, Kong APS, Fan B, Lee KF, Siu SC, Hui G, Tsang CC, Lau KP, Leung JY, Tsang MW, Kam G, Lau IT, Li JK, Yeung VT, Lau E, Lo S, Fung S, Cheng YL, Chow CC, Huang Y, Lan HY, Szeto CC, So WY, Chan JCN, Ma RCW, Hong Kong Diabetes Biobank Study Group.
    Am J Kidney Dis; 2022 Aug 07; 80(2):196-206.e1. PubMed ID: 34999159
    [Abstract] [Full Text] [Related]

  • 4. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A, van der Giet M, Kuhlmann MK, Martus P, Mielke N, Ebert N, Schaeffner ES.
    Am J Kidney Dis; 2021 Mar 07; 77(3):386-396.e1. PubMed ID: 33197533
    [Abstract] [Full Text] [Related]

  • 5. Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
    Neuen BL, Ohkuma T, Neal B, Matthews DR, de Zeeuw D, Mahaffey KW, Fulcher G, Blais J, Li Q, Jardine MJ, Perkovic V, Wheeler DC.
    Am J Kidney Dis; 2021 Jan 07; 77(1):23-34.e1. PubMed ID: 32971190
    [Abstract] [Full Text] [Related]

  • 6. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.
    Filippatos G, Anker SD, Pitt B, Rossing P, Joseph A, Kolkhof P, Lambelet M, Lawatscheck R, Bakris GL, Ruilope LM, Agarwal R.
    JACC Heart Fail; 2022 Nov 07; 10(11):860-870. PubMed ID: 36328655
    [Abstract] [Full Text] [Related]

  • 7. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
    Writing Group for the CKD Prognosis Consortium, Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar de Pinho N, Anderson A, Appel LJ, Ärnlöv J, Azizi F, Bansal N, Bell S, Bilo HJG, Brunskill NJ, Carrero JJ, Chadban S, Chalmers J, Chen J, Ciemins E, Cirillo M, Ebert N, Evans M, Ferreiro A, Fu EL, Fukagawa M, Green JA, Gutierrez OM, Herrington WG, Hwang SJ, Inker LA, Iseki K, Jafar T, Jassal SK, Jha V, Kadota A, Katz R, Köttgen A, Konta T, Kronenberg F, Lee BJ, Lees J, Levin A, Looker HC, Major R, Melzer Cohen C, Mieno M, Miyazaki M, Moranne O, Muraki I, Naimark D, Nitsch D, Oh W, Pena M, Purnell TS, Sabanayagam C, Satoh M, Sawhney S, Schaeffner E, Schöttker B, Shen JI, Shlipak MG, Sinha S, Stengel B, Sumida K, Tonelli M, Valdivielso JM, van Zuilen AD, Visseren FLJ, Wang AY, Wen CP, Wheeler DC, Yatsuya H, Yamagata K, Yang JW, Young A, Zhang H, Zhang L, Levey AS, Gansevoort RT.
    JAMA; 2023 Oct 03; 330(13):1266-1277. PubMed ID: 37787795
    [Abstract] [Full Text] [Related]

  • 8. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL, Barzi F, Hughes JT, Jerums G, O'Dea K, Brown AD, Ekinci EI, Jones GR, Lawton PD, Sinha A, MacIsaac RJ, Cass A, Maple-Brown LJ.
    Nephrology (Carlton); 2018 Jul 03; 23(7):682-689. PubMed ID: 28503768
    [Abstract] [Full Text] [Related]

  • 9. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
    Koeda Y, Tanaka F, Segawa T, Ohta M, Ohsawa M, Tanno K, Makita S, Ishibashi Y, Itai K, Omama SI, Onoda T, Sakata K, Ogasawara K, Okayama A, Nakamura M.
    BMC Nephrol; 2016 May 12; 17(1):46. PubMed ID: 27169575
    [Abstract] [Full Text] [Related]

  • 10. Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes.
    Rossing P, Groehl F, Mernagh P, Folkerts K, Garreta-Rufas A, Harris J, Meredith K, Carter M, Åkerborg Ö, Wanner C, Hobbs FDR.
    J Med Econ; 2023 May 12; 26(1):935-943. PubMed ID: 37439218
    [Abstract] [Full Text] [Related]

  • 11. Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.
    Neuen BL, Weldegiorgis M, Herrington WG, Ohkuma T, Smith M, Woodward M.
    Am J Kidney Dis; 2021 Sep 12; 78(3):350-360.e1. PubMed ID: 33895181
    [Abstract] [Full Text] [Related]

  • 12. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS, Wan EY, Chan AK, Lam CL.
    BMC Nephrol; 2017 Feb 02; 18(1):47. PubMed ID: 28152985
    [Abstract] [Full Text] [Related]

  • 13. Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort.
    Choi Y, Jacobs DR, Shroff GR, Kramer H, Chang AR, Duprez DA.
    J Am Heart Assoc; 2022 Nov 02; 11(21):e026685. PubMed ID: 36314497
    [Abstract] [Full Text] [Related]

  • 14. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
    Martin WP, Tuohy C, Doody A, Jackson S, Canavan RJ, Slattery D, Twomey PJ, McKenna MJ, le Roux CW, Docherty NG.
    Sci Rep; 2020 Sep 09; 10(1):14852. PubMed ID: 32908199
    [Abstract] [Full Text] [Related]

  • 15. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
    Freedman BI, Sink KM, Hugenschmidt CE, Hughes TM, Williamson JD, Whitlow CT, Palmer ND, Miller ME, Lovato LC, Xu J, Smith SC, Launer LJ, Barzilay JI, Cohen RM, Sullivan MD, Bryan RN, Wagner BC, Bowden DW, Maldjian JA, Divers J, AA-DHS MIND and ACCORD MIND Investigators.
    Am J Kidney Dis; 2017 Nov 09; 70(5):627-637. PubMed ID: 28648301
    [Abstract] [Full Text] [Related]

  • 16. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA, Raz I, Mosenzon O, Dwyer JP, Heerspink HHJL, Cahn A, Goodrich EL, Im K, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Gause-Nilsson I, Langkilde AM, Sabatine MS, Wiviott SD.
    JAMA Cardiol; 2021 Jul 01; 6(7):801-810. PubMed ID: 33851953
    [Abstract] [Full Text] [Related]

  • 17. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
    Agarwal R, Pitt B, Rossing P, Anker SD, Filippatos G, Ruilope LM, Kovesdy CP, Tuttle K, Vaduganathan M, Wanner C, Bansilal S, Gebel M, Joseph A, Lawatscheck R, Bakris GL.
    JAMA Cardiol; 2023 Aug 01; 8(8):732-741. PubMed ID: 37314801
    [Abstract] [Full Text] [Related]

  • 18. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function.
    Okubo A, Nakashima A, Doi S, Doi T, Ueno T, Maeda K, Tamura R, Yamane K, Masaki T.
    Clin Exp Nephrol; 2020 May 01; 24(5):435-443. PubMed ID: 32076888
    [Abstract] [Full Text] [Related]

  • 19. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes.
    Hong X, Huang L, Zhang Y, Shen X, Weng S, Zeng F, Zhao F, Yan S.
    Kidney Blood Press Res; 2021 May 01; 46(5):550-562. PubMed ID: 34428770
    [Abstract] [Full Text] [Related]

  • 20. The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes.
    Nichols GA, Déruaz-Luyet A, Hauske SJ, Brodovicz KG.
    J Diabetes Complications; 2018 Mar 01; 32(3):291-297. PubMed ID: 29352693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.